Lilian Shackelford Murray's most recent trade in Arcadia Biosciences Inc was a trade of 10,909 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcadia Biosciences Inc | Lilian Shackelford Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,909 | 13,287 | - | - | Stock Option (Right to Buy) | |
Arcadia Biosciences Inc | Lilian Shackelford Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 937 | 2,378 | - | - | Stock Option (Right to Buy) | |
Arcadia Biosciences Inc | Lilian Shackelford Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 23,620 | 57,765 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Lilian Shackelford Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,935 | 34,145 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Lilian Shackelford Murray | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2020 | 753 | 23,210 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Lilian Shackelford Murray | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 9,137 | 22,457 | - | - | Stock Option (right to buy) |